Universal Health Services Inc (UHS)
UndervaluedFundamental
83
Price
$186.89
Market Cap
$10.78B
Part 1 · What the company is worth
Overview
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$18.11B
Trailing 12 months (through 6/30/2026)
Net Income
$1.53B
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$849M
Total Equity
$7.28B
Total Liabilities
$8.19B
Current Ratio
1.12
Interest Coverage
13.05
Debt/EBITDA
2.01
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$340.91
Current Price
$186.89
Margin of Safety
+45.2%
Fair Value Range
$221.59 - $460.23
Spread across the valuation methods used, not a statistically calibrated confidence interval.
Estimation Methods
Valuation Metrics
P/E Ratio
7.63
ROE
20.5%
P/B Ratio
1.29
P/FCF
11.43
Gross Margin
-
ROIC
12.9%
Profitability Radar
Value Creation (Economic Moat)
ROIC
12.9%
WACC
7.9%
ROIC − WACC
+5.0 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Fundamental Analysis Criteria
Passed (22)
- EPS shows upward trend
- EPS CAGR 15.62%
- Price CAGR 5.74%
- ROIC 12.9%
- P/FCF 11.43
- P/B ratio 1.29
- Debt/equity ratio
- Operating margin 11.4%
- Positive free cash flow
- Current ratio
- Interest coverage
- Debt/EBITDA
- Return on tangible assets
- Price below Graham Number
- ROE 20.8%
- Revenue growth 5Y 8.5%
- Earnings surprise, average 4.4%
- PEG ratio 0.44
- Earnings quality (operating cash flow / net income) 1.18
- Share dilution -5.1%
- Net margin trend 8.4% vs 7.7%
- Piotroski F-Score 7/9
Failed (3)
- CapEx intensity
- Low reliance on intangibles
- DCF valuation (Unknown)
Unavailable (2)
- Gross margin –
- Dividend payout –
Piotroski F-Score
Strong financial health
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Institutional Holdings
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Alan B. Miller | Founder & Executive Chairman of the Board | 87 |
| Mr. Marc D. Miller | CEO, President & Director | 54 |
| Mr. Steve G. Filton | Executive VP, CFO & Secretary | 67 |
| Mr. Edward H. Sim | Executive VP & President of Acute Care Division | 53 |
| Mr. Darren P. Lehrich | Vice President of Investor Relations | 53 |
| Mr. Matthew David Klein | Senior VP & General Counsel | - |
| Ms. Maria Zangardi | Senior Vice President of Human Resources | - |
| Mr. Michael S. Nelson | Senior Vice President of Strategic Services | - |
| Mr. Jim Clark | Senior Vice President of Finance - Acute Care Division | - |
| Thomas Day | Senior Vice President of Finance - Behavioral Health Division | - |
Audit Risk
9
Board Risk
10
Compensation Risk
8
Shareholder Rights Risk
10
Documents
- View document
Annual Report (10-K)
A yearly overview of the business, its financial results, and the risks it faces.
Filed on 2026-02-25
- View document
Quarterly Report (10-Q)
A snapshot of financial performance for the most recent three-month period.
Filed on 2026-08-07
- View document
Current Report (8-K)
An announcement of a major event, such as a leadership change or big news.
Filed on 2026-08-21
via SEC EDGAR
Income History
via SEC EDGAR
Part 2 · The price and its context
This part shows how the price has behaved, not whether the company is worth owning. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Market Reaction Profile
How much UHS moves, measured on its daily prices.
More volatile than 33% of the tracked stocks (90-day volatility).
- Volatility 30d
- 24.8%
- Volatility 90d
- 29.5%
- Beta vs S&P 500 (1y)
- 0.10Correlation 0.04
- Max drawdown (12m)
- -42.2%
- ATR (14d, % of price)
- 2.55%
Earnings reactions
How UHS moved around its past quarterly results.
Next earnings release
Oct 27, 2026 · In 3 days · After the close
EPS estimate: 5.15Revenue estimate: $4.7B
What usually happens
- Over the last 12 releases the stock moved a median of 3.8% the next day, up or down.
- Next-day moves: up 6, down 6 (out of 12).
Release history
| Date | When | EPS est. | EPS actual | Surprise | Gap | 1 day | 5 days |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | During the session | 6.02 | 5.98 | -0.6% | -6.1% | +4.3% | +6.1% |
| Apr 28, 2026 | During the session | 5.46 | 5.62 | +2.9% | +2.5% | -9.5% | -7.5% |
| Feb 26, 2026 | During the session | 5.96 | 5.88 | -1.3% | -4.9% | -11.4% | -12.3% |
| Oct 28, 2025 | During the session | 4.88 | 5.69 | +16.5% | +2.8% | +2.5% | +3.1% |
| Jul 29, 2025 | During the session | n/a | n/a | n/a | -0.7% | +5.1% | +6.3% |
| Apr 29, 2025 | During the session | n/a | n/a | n/a | -2.6% | -0.6% | +3.1% |
| Feb 27, 2025 | During the session | n/a | n/a | n/a | +5.5% | +3.3% | -1.3% |
| Oct 25, 2024 | During the session | n/a | n/a | n/a | -7.4% | -9.8% | -9.1% |
| Jul 25, 2024 | During the session | n/a | n/a | n/a | +3.3% | +10.2% | +14.9% |
| Apr 25, 2024 | During the session | n/a | n/a | n/a | +5.5% | -0.5% | +2.6% |
| Feb 27, 2024 | After the close | n/a | n/a | n/a | +2.9% | -2.4% | +5.9% |
| Oct 26, 2023 | During the session | n/a | n/a | n/a | 0.0% | +1.7% | +2.6% |
Release dates from SEC 8-K filings.
Updated 10/24/2026
Historical statistics for educational purposes only. They are not forecasts and not investment advice.
Price reaction to the news
Latest news on UHS and what the price did next.
Return of the stock minus return of SPY over the same days. A news item close to a price move did not necessarily cause it. Historical data for educational purposes only, not investment advice.
Latest News
Recent headlines for UHS.